Activation of the alternative pathway of human complement by haemoglobin
- PMID: 111881
- PMCID: PMC1537709
Activation of the alternative pathway of human complement by haemoglobin
Abstract
Haemoglobin solutions (concentration greater than 1.5 mg/ml), prepared from lysates of erythrocytes from a normal subject and from a patient with sickle cell anaemia, caused factor B and C3 cleavage and loss of haemolytic activity of factor B wehn incubated with fresh autologous serum. Under the same experimental conditions, preparations of erythrocyte stroma or of buffycoat lysates did not produce factor B and C3 cleavage. This reaction required Mg++ but not C1q or C4, indicating that the alternative complement pathway was activated.
Similar articles
-
Plasma haemoglobin and complement activation in sickle cell disease.J Clin Lab Immunol. 1981 Jul;6(1):57-60. J Clin Lab Immunol. 1981. PMID: 7265176
-
Interactions of chrysotile asbestos fibres with the complement system.Immunology. 1980 Oct;41(2):431-7. Immunology. 1980. PMID: 6904360 Free PMC article.
-
Activation of the alternative pathway of complement by human peripheral nerve myelin.J Immunol. 1985 Mar;134(3):1810-4. J Immunol. 1985. PMID: 2578522
-
Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.J Immunol. 1998 Mar 15;160(6):3006-13. J Immunol. 1998. PMID: 9510205
-
Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.Int Immunopharmacol. 2005 Jun;5(6):1077-84. doi: 10.1016/j.intimp.2005.02.007. Int Immunopharmacol. 2005. PMID: 15829423
Cited by
-
Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.J Clin Invest. 1993 Sep;92(3):1326-35. doi: 10.1172/JCI116706. J Clin Invest. 1993. PMID: 7690777 Free PMC article.
-
Hyperlipidemia in acute hemolysis.Klin Wochenschr. 1991 Jul 22;69(10):426-9. doi: 10.1007/BF01666827. Klin Wochenschr. 1991. PMID: 1942954
-
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.Mol Ther. 2018 Oct 3;26(10):2337-2356. doi: 10.1016/j.ymthe.2018.07.011. Epub 2018 Jul 17. Mol Ther. 2018. PMID: 30093306 Free PMC article. Review.
-
Inhibition of cell-free oxidative bactericidal activity by erythrocytes and hemoglobin.Infect Immun. 1984 May;44(2):465-8. doi: 10.1128/iai.44.2.465-468.1984. Infect Immun. 1984. PMID: 6325349 Free PMC article.
-
Life-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review.Front Pediatr. 2020 Feb 20;8:38. doi: 10.3389/fped.2020.00038. eCollection 2020. Front Pediatr. 2020. PMID: 32154192 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous